Hereditary Nonpolyposis Colorectal Cancer Differential Diagnoses

1. Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology. 2010 Jun. 138 (6):2073-87.e3. [QxMD MEDLINE Link].

2. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology. 1999 Jun. 116 (6):1453-6. [QxMD MEDLINE Link].

3. Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology. 2010 Jun. 138 (6):2073-87.e3. [QxMD MEDLINE Link].

4. Vilar E, Gruber SB. Microsatellite instability in colorectal cancer-the stable evidence. Nat Rev Clin Oncol. 2010 Mar. 7 (3):153-62. [QxMD MEDLINE Link].

5. Ismael NE, El Sheikh SA, Talaat SM, Salem EM. Mismatch repair proteins and microsatellite instability in colorectal carcinoma (MLH1, MSH2, MSH6 and PMS2): histopathological and immunohistochemical study. Open Access Maced J Med Sci. 2017 Mar 15. 5 (1):9-13. [QxMD MEDLINE Link].

6. Chen W, Swanson BJ, Frankel WL. Molecular genetics of microsatellite-unstable colorectal cancer for pathologists. Diagn Pathol. 2017 Mar 4. 12 (1):24. [QxMD MEDLINE Link].

7. Mizoguchi H, O'Shea JJ, Longo DL, Loeffler CM, McVicar DW, Ochoa AC. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science. 1992 Dec 11. 258 (5089):1795-8. [QxMD MEDLINE Link].

8. Aarnio M, Mecklin JP, Aaltonen LA, Nystrom-Lahti M, Jarvinen HJ. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer. 1995 Dec 20. 64 (6):430-3. [QxMD MEDLINE Link].

9. Houlston RS, Murday V, Harocopos C, Williams CB, Slack J. Screening and genetic counselling for relatives of patients with colorectal cancer in a family cancer clinic. BMJ. 1990 Aug 18-25. 301 (6748):366-8. [QxMD MEDLINE Link]. [Full Text].

10. Ladabaum U, Wang G, Terdiman J, et al. Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. Ann Intern Med. 2011 Jul 19. 155 (2):69-79. [QxMD MEDLINE Link].

11. Hamilton SR, Liu B, Parsons RE, et al. The molecular basis of Turcot's syndrome. N Engl J Med. 1995 Mar 30. 332 (13):839-47. [QxMD MEDLINE Link]. [Full Text].

12. Bhaijee F, Brown AS. Muir-Torre syndrome. Arch Pathol Lab Med. 2014 Dec. 138 (12):1685-9. [QxMD MEDLINE Link].

13. American Cancer Society. Genetic testing, screening, and prevention for people with a strong family history of colorectal cancer. Available at https://www.cancer.org/content/cancer/en/cancer/colon-rectal-cancer/causes-risks-prevention/genetic-tests-screening-prevention.html. Revised: March 2, 2017; Accessed: March 22, 2017.

14. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004 Feb 18. 96 (4):261-8. [QxMD MEDLINE Link]. [Full Text].

15. [Guideline] Syngal S, Brand RE, Church JM, et al, for the American College of Gastroenterology. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015 Feb. 110 (2):223-62; quiz 263. [QxMD MEDLINE Link].

16. Lothe RA, Peltomäki P, Meling GI, et al. Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res. 1993 Dec 15. 53 (24):5849-52. [QxMD MEDLINE Link].

17. Marra G, Boland CR. Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst. 1995 Aug 2. 87 (15):1114-25. [QxMD MEDLINE Link].

18. Dunlop MG, Farrington SM, Carothers AD, et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet. 1997 Jan. 6 (1):105-10. [QxMD MEDLINE Link]. [Full Text].

19. American Cancer Society. Cancer facts & figures 2017. Atlanta, Ga: American Cancer Society; 2017. Available at https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2017.html. Accessed: March 23, 2017.

20. [Guideline] Levin B, Lieberman DA, McFarland B, et al, for the American Cancer Society Colorectal Cancer Advisory Group; US Multi-Society Task Force; American College of Radiology Colon Cancer Committee. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008 May. 134(5):1570-95. [QxMD MEDLINE Link].

21. Giraldez MD, Balaguer F, Bujanda L, et al. MSH6 and MUTYH deficiency is a frequent event in early-onset colorectal cancer. Clin Cancer Res. 2010 Nov 15. 16 (22):5402-13. [QxMD MEDLINE Link].

22. American Cancer Society. American Cancer Society recommendations for colorectal cancer early detection. Available at https://www.cancer.org/cancer/colon-rectal-cancer/detection-diagnosis-staging/acs-recommendations.html. Revised: March 1, 2017; Accessed: March 22, 2017.

23. American Cancer Society. Colorectal cancer screening tests. Available at https://www.cancer.org/cancer/colon-rectal-cancer/detection-diagnosis-staging/screening-tests-used.html. Revised: March 2, 2017; Accessed: March 22, 2017.

24. Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al. A National Cancer Institute Workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst. 1997 Dec 3. 89 (23):1758-62. [QxMD MEDLINE Link]. [Full Text].

25. Zhang L. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing. J Mol Diagn. 2008 Jul. 10 (4):301-7. [QxMD MEDLINE Link]. [Full Text].

26. Weissman SM, Bellcross C, Bittner CC, et al. Genetic counseling considerations in the evaluation of families for Lynch syndrome--a review. J Genet Couns. 2011 Feb. 20 (1):5-19. [QxMD MEDLINE Link].

27. Vasen HF, Nagengast FM, Griffioen G, et al for the Work Group 'Hereditary non-polyposis- colon-rectum cancers'. [Periodic colonoscopic examinations of persons with a positive family history for colorectal cancer. Work Group 'Hereditary non-polyposis- colon-rectum cancers'] [Dutch]. Ned Tijdschr Geneeskd. 1999 Jun 5. 143 (23):1211-4. [QxMD MEDLINE Link].

28. [Guideline] Smith RA, von Eschenbach AC, Wender R, et al, for the ACS Prostate Cancer Advisory Committee, ACS Colorectal Cancer Advisory Committee, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001--testing for early lung cancer detection. CA Cancer J Clin. 2001 Jan-Feb. 51(1):38-75; quiz 77-80. [QxMD MEDLINE Link]. [Full Text].

29. [Guideline] Winawer S, Fletcher R, Rex D, et al, for the Gastrointestinal Consortium Panel. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology. 2003 Feb. 124(2):544-60. [QxMD MEDLINE Link].

30. Love RR, Morrissey JF. Colonoscopy in asymptomatic individuals with a family history of colorectal cancer. Arch Intern Med. 1984 Nov. 144 (11):2209-11. [QxMD MEDLINE Link].

31. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum. 1991 May. 34 (5):424-5. [QxMD MEDLINE Link].

32. Mecklin JP, Järvinen HJ, Peltokallio P. Cancer family syndrome. Genetic analysis of 22 Finnish kindreds. Gastroenterology. 1986 Feb. 90 (2):328-33. [QxMD MEDLINE Link].

33. [Guideline] National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines): colorectal cancer screening. V 2.2016. Available at https://www.nccn.org/professionals/physician_gls/pdf/colorectal_screening.pdf. Accessed: March 23, 2017.

34. Lindor NM, Petersen GM, Hadley DW, et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA. 2006 Sep 27. 296 (12):1507-17. [QxMD MEDLINE Link].

35. Ramsoekh D, Wagner A, van Leerdam ME, et al. Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management. Hered Cancer Clin Pract. 2009 Dec 23. 7 (1):17. [QxMD MEDLINE Link]. [Full Text].

36. Bonadona V, Bonaiti B, Olschwang S, et al, for the French Cancer Genetics Network. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA. 2011 Jun 8. 305 (22):2304-10. [QxMD MEDLINE Link].

37. National Cancer Institute. Genetics of colorectal cancer (PDQ)–health professional version. Available at https://www.cancer.gov/types/colorectal/hp/colorectal-genetics-pdq. Updated: March 16, 2017; Accessed: March 22, 2017.

38. Hampel H, Frankel W, Panescu J, et al. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res. 2006 Aug 1. 66 (15):7810-7. [QxMD MEDLINE Link]. [Full Text].

39. Renkonen-Sinisalo L, Sipponen P, Aarnio M, et al. No support for endoscopic surveillance for gastric cancer in hereditary non-polyposis colorectal cancer. Scand J Gastroenterol. 2002 May. 37 (5):574-7. [QxMD MEDLINE Link].

40. Ramsey SD. Screening for the Lynch syndrome. N Engl J Med. 2005 Aug 4. 353 (5):524-5; author reply 524-5. [QxMD MEDLINE Link].

41. Hampel H, Frankel WL, Martin E, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med. 2005 May 5. 352 (18):1851-60. [QxMD MEDLINE Link]. [Full Text].

42. Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer. 1993 Feb 1. 71 (3):677-85. [QxMD MEDLINE Link].

43. Bliss CM Jr, Schroy PC 3rd. Endoscopic diagnosis and management of hereditary nonpolyposis colorectal cancer. Curr Opin Gastroenterol. 2004 Sep. 20 (5):468-73. [QxMD MEDLINE Link].

44. Foster JH. Survival after liver resection for cancer. Cancer. 1970 Sep. 26 (3):493-502. [QxMD MEDLINE Link].

45. Exelby PR, Filler RM, Grosfeld JL. Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of Pediatrics Surgical Section Survey--1974. J Pediatr Surg. 1975 Jun. 10 (3):329-37. [QxMD MEDLINE Link].

46. Weinberger JM, Cohen Z, Berk T. Polyposis coli preceded by hepatocellular carcinoma: report of a case. Dis Colon Rectum. 1981 May-Jun. 24 (4):296-300. [QxMD MEDLINE Link].

47. Lanspa SJ, Jenkins JX, Cavalieri RJ, et al. Surveillance in Lynch syndrome: how aggressive?. Am J Gastroenterol. 1994 Nov. 89 (11):1978-80. [QxMD MEDLINE Link].

48. de Vos tot Nederveen Cappel WH, Nagengast FM, Griffioen G, et al. Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families. Dis Colon Rectum. 2002 Dec. 45 (12):1588-94. [QxMD MEDLINE Link].

49. Syngal S, Weeks JC, Schrag D, Garber JE, Kuntz KM. Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Ann Intern Med. 1998 Nov 15. 129 (10):787-96. [QxMD MEDLINE Link]. [Full Text].

50. Stupart DA, Goldberg PA, Baigrie RJ, Algar U, Ramesar R. Surgery for colonic cancer in HNPCC: total vs segmental colectomy. Colorectal Dis. 2011 Dec. 13 (12):1395-9. [QxMD MEDLINE Link].

51. Chan TA. Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention. Lancet Oncol. 2002 Mar. 3 (3):166-74. [QxMD MEDLINE Link].

52. O'Shaughnessy JA, Kelloff GJ, Gordon GB, et al. Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development. Clin Cancer Res. 2002 Feb. 8 (2):314-46. [QxMD MEDLINE Link]. [Full Text].

53. DuBois RN, Smalley WE. Cyclooxygenase, NSAIDs, and colorectal cancer. J Gastroenterol. 1996 Dec. 31 (6):898-906. [QxMD MEDLINE Link].

54. Sinicrope FA, Half E, Morris JS, et al, Familial Adenomatous Polyposis Study Group. Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients. Cancer Epidemiol Biomarkers Prev. 2004 Jun. 13 (6):920-7. [QxMD MEDLINE Link]. [Full Text].

55. Markowitz SD. Aspirin and colon cancer--targeting prevention?. N Engl J Med. 2007 May 24. 356 (21):2195-8. [QxMD MEDLINE Link].

56. Burn J, Gerdes AM, Macrae F, et al, for the, CAPP2 Investigators. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet. 2011 Dec 17. 378 (9809):2081-7. [QxMD MEDLINE Link]. [Full Text].

57. Cole BF, Baron JA, Sandler RS, et al, for the Polyp Prevention Study Group. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA. 2007 Jun 6. 297 (21):2351-9. [QxMD MEDLINE Link]. [Full Text].

58. Giovannucci E, Stampfer MJ, Colditz GA, et al. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med. 1998 Oct 1. 129 (7):517-24. [QxMD MEDLINE Link]. [Full Text].

59. Baron JA, Beach M, Mandel JS, et al, for the Calcium Polyp Prevention Study Group. Calcium supplements for the prevention of colorectal adenomas. N Engl J Med. 1999 Jan 14. 340 (2):101-7. [QxMD MEDLINE Link]. [Full Text].

60. Grau MV, Baron JA, Sandler RS, et al. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst. 2003 Dec 3. 95 (23):1765-71. [QxMD MEDLINE Link]. [Full Text].

61. Wu K, Willett WC, Fuchs CS, Colditz GA, Giovannucci EL. Calcium intake and risk of colon cancer in women and men. J Natl Cancer Inst. 2002 Mar 20. 94 (6):437-46. [QxMD MEDLINE Link]. [Full Text].

62. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, et al, for the Women's Health Initiative Investigators. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med. 2004 Mar 4. 350 (10):991-1004. [QxMD MEDLINE Link]. [Full Text].

63. Chlebowski RT, Anderson GL. Menopausal hormone therapy and cancer: changing clinical observations of target site specificity. Steroids. 2014 Nov. 90:53-9. [QxMD MEDLINE Link].

64. Slattery ML, Caan BJ, Potter JD, et al. Dietary energy sources and colon cancer risk. Am J Epidemiol. 1997 Feb 1. 145 (3):199-210. [QxMD MEDLINE Link]. [Full Text].

65. Colangelo LA, Gapstur SM, Gann PH, Dyer AR. Cigarette smoking and colorectal carcinoma mortality in a cohort with long-term follow-up. Cancer. 2004 Jan 15. 100 (2):288-93. [QxMD MEDLINE Link]. [Full Text].

66. Nilsen TI, Vatten LJ. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis. Br J Cancer. 2001 Feb 2. 84 (3):417-22. [QxMD MEDLINE Link]. [Full Text].

67. Agiannidis C, Pana ZD, Molyva D, Kalokasidis K, Mixiou M. Metachronous occurrence of colorectal cancer in a Muir-Torre syndrome patient presenting with recurrent sebaceous adenoma of the eyelid: case report and updated review of the literature. J Cutan Med Surg. 2012 Nov-Dec. 16 (6):394-9. [QxMD MEDLINE Link].

68. Brixen LM, Bernstein IT, Bülow S, Ehrnrooth E. Survival of patients with Stage III colon cancer is improved in hereditary non-polyposis colorectal cancer compared with sporadic cases. A Danish registry based study. Colorectal Dis. 2013 Jul. 15 (7):816-23. [QxMD MEDLINE Link].

69. Bronner CE, Baker SM, Morrison PT, et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature. 1994 Mar 17. 368 (6468):258-61. [QxMD MEDLINE Link].

70. Burn J, Mathers J, Bishop DT. Genetics, inheritance and strategies for prevention in populations at high risk of colorectal cancer (CRC). Recent Results Cancer Res. 2013. 191:157-83. [QxMD MEDLINE Link].

71. Calistri D, Presciuttini S, Buonsanti G, et al. Microsatellite instability in colorectal-cancer patients with suspected genetic predisposition. Int J Cancer. 2000 Jan 20. 89 (1):87-91. [QxMD MEDLINE Link]. [Full Text].

72. Church JM. Prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer. Ann Med. 1996 Dec. 28 (6):479-82. [QxMD MEDLINE Link].

73. Cummings JH, Bingham SA. Diet and the prevention of cancer. BMJ. 1998 Dec 12. 317 (7173):1636-40. [QxMD MEDLINE Link]. [Full Text].

74. Feldman M, Friedman LS, Brandt LJ. Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. Philadelphia, Pa: Saunders Elsevier; 2006.

75. Heiskanen I, Jarvinen HJ. Fate of the rectal stump after colectomy and ileorectal anastomosis for familial adenomatous polyposis. Int J Colorectal Dis. 1997. 12 (1):9-13. [QxMD MEDLINE Link].

76. Hendriks YM, de Jong AE, Morreau H, et al. Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma): a guide for clinicians. CA Cancer J Clin. 2006 Jul-Aug. 56 (4):213-25. [QxMD MEDLINE Link]. [Full Text].

77. Jarvinen TA, Pelto-Huikko M, Holli K, Isola J. Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer. Am J Pathol. 2000 Jan. 156 (1):29-35. [QxMD MEDLINE Link]. [Full Text].

78. Kacerovska D, Cerna K, Martinek P, et al. MSH6 mutation in a family affected by Muir-Torre syndrome. Am J Dermatopathol. 2012 Aug. 34 (6):648-52. [QxMD MEDLINE Link].

79. Lanspa SJ, Jenkins JX, Watson P, et al. Natural history of at-risk Lynch syndrome family members with respect to adenomas. Nebr Med J. 1992 Nov. 77 (11):310-3. [QxMD MEDLINE Link].

80. Lin KM, Shashidharan M, Ternent CA, et al. Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population. Dis Colon Rectum. 1998 Apr. 41 (4):428-33. [QxMD MEDLINE Link].

81. Lindor NM, Petersen GM, Hadley DW, et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA. 2006 Sep 27. 296 (12):1507-17. [QxMD MEDLINE Link]. [Full Text].

82. Lynch HT. Is there a role for prophylactic subtotal colectomy among hereditary nonpolyposis colorectal cancer germline mutation carriers?. Dis Colon Rectum. 1996 Jan. 39 (1):109-10. [QxMD MEDLINE Link].

83. Lynch HT, Boland CR, Gong G, et al. Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications. Eur J Hum Genet. 2006 Apr. 14 (4):390-402. [QxMD MEDLINE Link]. [Full Text].

84. Lynch HT, Krush AJ. Cancer family "G" revisited: 1895-1970. Cancer. 1971 Jun. 27 (6):1505-11. [QxMD MEDLINE Link].

85. Lynch HT, Riley BD, Weissman SM, et al. Hereditary nonpolyposis colorectal carcinoma (HNPCC) and HNPCC-like families: Problems in diagnosis, surveillance, and management. Cancer. 2004 Jan 1. 100 (1):53-64. [QxMD MEDLINE Link]. [Full Text].

86. Mizoguchi T, Yamada K, Furukawa T, et al. Expression of the MDR1 gene in human gastric and colorectal carcinomas. J Natl Cancer Inst. 1990 Nov 7. 82 (21):1679-83. [QxMD MEDLINE Link].

87. Nugent KP, Spigelman AD, Phillips RK. Life expectancy after colectomy and ileorectal anastomosis for familial adenomatous polyposis. Dis Colon Rectum. 1993 Nov. 36 (11):1059-62. [QxMD MEDLINE Link].

88. Schmeler KM, Lynch HT, Chen LM, et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med. 2006 Jan 19. 354 (3):261-9. [QxMD MEDLINE Link]. [Full Text].

89. Macaron C, Leach BH, Burke CA. Hereditary colorectal cancer syndromes and genetic testing. J Surg Oncol. 2015 Jan. 111 (1):103-11. [QxMD MEDLINE Link].

90. Kalady MF, Heald B. Diagnostic approach to hereditary colorectal cancer syndromes. Clin Colon Rectal Surg. 2015 Dec. 28 (4):205-14. [QxMD MEDLINE Link].

91. Lindberg LJ, Ladelund S, Frederiksen BL, Smith-Hansen L, Bernstein I. Outcome of 24 years national surveillance in different hereditary colorectal cancer subgroups leading to more individualised surveillance. J Med Genet. 2017 May. 54 (5):297-304. [QxMD MEDLINE Link].

92. Shawki S, Kalady MF. Recent advances in understanding Lynch syndrome. F1000Res. 2016 Dec 21. 5:2889. [QxMD MEDLINE Link].

93. Chen CH, Sheng Jiang S, et al. DNA methylation identifies loci distinguishing hereditary nonpolyposis colorectal cancer without germ-line MLH1/MSH2 mutation from sporadic colorectal cancer. Clin Transl Gastroenterol. 2016 Dec 15. 7 (12):e208. [QxMD MEDLINE Link].

94. Gelsomino F, Barbolini M, Spallanzani A, Pugliese G, Cascinu S. The evolving role of microsatellite instability in colorectal cancer: a review. Cancer Treat Rev. 2016 Dec. 51:19-26. [QxMD MEDLINE Link].

95. Rohlin A, Rambech E, Kvist A, et al. Expanding the genotype-phenotype spectrum in hereditary colorectal cancer by gene panel testing. Fam Cancer. 2017 Apr. 16 (2):195-203. [QxMD MEDLINE Link].

96. Moller P, Seppala T, Bernstein I, et al, for the Mallorca Group. Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database. Gut. 2017 Mar. 66 (3):464-72. [QxMD MEDLINE Link].

97. Guivatchian T, Koeppe ES, Baker JR, et al. Family history in colonoscopy patients: feasibility and performance of electronic and paper-based surveys for colorectal cancer risk assessment in the outpatient setting. Gastrointest Endosc. 2017 Oct. 86 (4):684-91. [QxMD MEDLINE Link].

98. Gould-Suarez M, El-Serag HB, Musher B, Franco LM, Chen GJ. Cost-effectiveness and diagnostic effectiveness analyses of multiple algorithms for the diagnosis of Lynch syndrome. Dig Dis Sci. 2014 Dec. 59 (12):2913-26. [QxMD MEDLINE Link].

99. Mensenkamp AR, Vogelaar IP, van Zelst-Stams WA, et al. Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors. Gastroenterology. 2014 Mar. 146 (3):643-6.e8. [QxMD MEDLINE Link].

100. Hegde M, Ferber M, Mao R, Samowitz W, Ganguly A, for the Working Group of the American College of Medical Genetics and Genomics (ACMG) Laboratory Quality Assurance Committee. ACMG technical standards and guidelines for genetic testing for inherited colorectal cancer (Lynch syndrome, familial adenomatous polyposis, and MYH-associated polyposis). Genet Med. 2014 Jan. 16 (1):101-16. [QxMD MEDLINE Link].

101. [Guideline] National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines): genetic/familial high-risk assessment: colorectal. V 2.2016. Available at https://www.nccn.org/professionals/physician_gls/pdf/genetics_colon.pdf. Accessed: March 23, 2017.

Juan Carlos Munoz, MD Associate Professor of Medicine and Director of the Endoscopy Unit, Division of Gastroenterology, University of Florida College of Medicine at Jacksonville

Juan Carlos Munoz, MD is a member of the following medical societies: American College of Physicians, American Gastroenterological Association, American Society for Gastrointestinal Endoscopy

Disclosure: Nothing to disclose.

Louis R Lambiase, MD, MHA Professor of Medicine, University of Tennessee College of Medicine Chattanooga; Chief, Division of Gastroenterology, University of Tennessee Chattanooga Unit; Assistant Dean for Clinical Affairs, University of Tennessee College of Medicine Chattanooga

Louis R Lambiase, MD, MHA is a member of the following medical societies: American Gastroenterological Association, American Pancreatic Association, American Society for Gastrointestinal Endoscopy

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

BS Anand, MD Professor, Department of Internal Medicine, Division of Gastroenterology, Baylor College of Medicine

BS Anand, MD is a member of the following medical societies: American Association for the Study of Liver Diseases, American College of Gastroenterology, American Gastroenterological Association, American Society for Gastrointestinal Endoscopy

Disclosure: Nothing to disclose.

Simmy Bank, MD Chair, Professor, Department of Internal Medicine, Division of Gastroenterology, Long Island Jewish Hospital, Albert Einstein College of Medicine

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article